Wadhane Jitendra
SEC CIK 1941706 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| PYXS | Pyxis Oncology, Inc. | SVP, CAO | 512.9K | $17.9K | — | 8 | 2023-03-24 | 2026-03-24 |
Most active insiders at PYXS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Dupont Jakob | Dir | — | $107.1K |
| 2 | Wadhane Jitendra | Prin Fin, Acct Off | — | — |
Transactions 8
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-25 | 2026-03-24 | PYXS | Pyxis Oncology, Inc. | Wadhane Jitendra | Prin Fin, Acct Off | A - Grant | $0.00 | +109.5K | 512.9K | +27% | $0 |
| 2024-03-28 | 2024-03-26 | PYXS | Pyxis Oncology, Inc. | Wadhane Jitendra | SVP, CAO | A - Grant | $0.00 | +131.5K | 398.4K | +49% | $0 | |
| 2023-11-17 | 2023-11-15 | PYXS | Pyxis Oncology, Inc. | Wadhane Jitendra | CAO | A - Grant | $0.00 | +40.0K | 266.9K | +18% | $0 | |
| 2023-09-27 | 2023-09-27 | PYXS | Pyxis Oncology, Inc. | Wadhane Jitendra | CAO | P - Purchase | $1.87 | +2,500 | 226.9K | +1% | +$4,675 | |
| 2023-09-25 | 2023-09-25 | PYXS | Pyxis Oncology, Inc. | Wadhane Jitendra | CAO | P - Purchase | $1.77 | +5,000 | 224.4K | +2% | +$8,850 | |
| 2023-09-22 | 2023-09-22 | PYXS | Pyxis Oncology, Inc. | Wadhane Jitendra | CAO | P - Purchase | $1.74 | +2,500 | 219.4K | +1% | +$4,350 | |
| 2023-09-08 | 2023-09-07 | PYXS | Pyxis Oncology, Inc. | Wadhane Jitendra | CAO | A - Grant | $0.00 | +93.9K | 211.9K | +80% | $0 | |
| DM | 2023-03-28 | 2023-03-24 | PYXS | Pyxis Oncology, Inc. | Wadhane Jitendra | CAO | A - Grant | $0.00 | +74.4K | 88.6K | +522% | $0 |
Purchase Sale Sale after option exercise All abbreviations